Lorlatinib 25-100 MG
Product Details:
-
Origin of Medicine
Synthetic
-
Salt Composition
Lorlatinib
-
Pacakaging (Quantity Per Box)
Typically 30 tablets per box
-
Drug Type
Antineoplastic agent
-
Ingredients
Lorlatinib
-
Physical Form
Tablet
-
Function
Used for the treatment of ALK-positive metastatic non-small cell lung cancer (NSCLC)
-
Lorlatinib 25-100 MG Product Specifications
-
Lorlatinib
-
As prescribed by a healthcare professional; typically once daily with or without food
-
Patients with ALK-positive metastatic non-small cell lung cancer
-
Synthetic
-
Store at room temperature (20-25C) protect from light and moisture
-
25-100 MG
-
Antineoplastic agent
-
Varies based on packaging (e.g. 30 tablets per bottle)
-
Lorlatinib
-
Adults diagnosed with ALK-positive NSCLC
-
Used for the treatment of ALK-positive metastatic non-small cell lung cancer (NSCLC)
-
Tablet
-
Typically 30 tablets per box
Other Products in 'Common Medicines & Drugs' category
Back to top |